Aurobindo Pharma

Aurobindo Pharma posts Q4/FY2014-15 results

Total operating income was up by 35.7 per cent to Rs 3162.1 crores in Q4 FY2014-15 Aurobindo Pharma has posted its Q4/FY2014-15 results. In Q4 FY2014-15, the total operating income was up by 35.7 per cent to Rs 3162.1 crores

Pharmexcil organises series of initiatives during CPhI Japan

Brand India Pharma was strongly represented by Indian pharma companies at various platforms

Cabinet clears Rs 4,187-crore Glenmark, Aurobindo proposals

The decision was taken by CCEA, chaired by Prime Minister Narendra Modi

Aurobindo Pharma receives US FDA approval for Cefixime for oral suspension USP

Cefixime for oral suspension is indicated for the treatment of adults and paediatric patients six months of age or older

Aurobindo divests Australian arm to Eris Pharma

Aurobindo Pharma has divested stake in its Australian subsidiary to Eris Pharma for an undisclosed amount to focus on the US, European and emerging markets...

aurobindo pharma, bse sensex

Plethico to pay Aurobindo Pharma $23.3 million to settle dispute

Aurobindo Pharma had emerged as the highest bidder for acquisition of Natrol Inc, US

Aurobindo Pharma receives US FDA approval

Atracurium Besylate injections are indicated as an adjunct to general anaesthesia

Aurobindo Pharma receives US FDA Approval for Sildenafil injection

Sildenafil injection is indicated for the treatment of adult patients (≥ 18 years) with pulmonary arterial hypertension who are temporarily unable to take oral therapy

Aurobindo, Tergene to form JV for pneumonia vaccine

Aurobindo Pharma has decided to form a joint venture with Hyderabad-based Tergene Biotech, a vaccine development company...

Bullish on Aurobindo Pharma on robust growth: HSBC

Aurobindo Pharma has demonstrated its strength in high-value generic formulations outside its established expertise in antibiotic...

Aurobindo Pharma to raise USD 350 million through Qualified Institutions Placement

Aurobindo Pharma Limited today said the company will raise up to USD 350 million by way of Qualified Institutions Placement (QIP)...

Aurobindo Pharma, Aurobindo Pharma QIP, Aurobindo Pharma news, Aurobindo Pharma latest, Aurobindo Pharma money issues, Aurobindo Pharma value

Aurobindo Pharma to raise Rs 2157.92 crore through QIP

According to report in PTI, Aurobindo Pharma will raise up to $350 million (Rs 2157.92 crore) by way of Qualified Institutional Placement (QIP)

Jubilant Life Sciences, Lupin and Aurobindo Pharma receives US FDA approval for Valsartan tabs

Jubilant Life Sciences, Lupin and Aurobindo Pharma have received final approval from the US Food and Drug Administration (US FDA) for Valsartan tablets USP, 40 mg, 80 mg, 160 mg and 320 mg, the generic version of Diovan (of N

Aurobindo completes the acquisition of Natrol

Aurobindo Pharma announced the completion of acquisition of assets of nutritional supplement maker, Natrol Inc. and other affiliate entities (Natrol) through its wholly owned subsidiary Aurobindo Pharma US Inc (APUSA)

Aurobindo Pharma completes acquisition of Natrol

APUSA emerged as the highest and best bidder to acquire assets of Natrol under the auction process by the United States Bankruptcy Court for the District of Delaware

Suspension of 1,500 employees cripples Aurobindo unit operations

Aurobindo Pharma's decision to suspend over 1,500 employees at its Unit XI at Pydibhimavaram...

Aurobindo Pharma US arm recalls epilepsy drug over empty capsules

Aurobindo Pharma’s US subsidiary has said it has voluntarily recalled 300-mg...

Aurobindo Pharma vice-chairman escapes possible kidnap attempt

An unidentified person shot at K Nityananda Reddy, wholetime director and vice-chairman, Aurobindo Pharma...

AK-47 rifle wielding man tries to kidnap top Aurobindo Pharma official in Hyderabad

The unidentified attacker sat in Aurobindo Pharma's Director K Nityananda Reddy's car and then threatened him at gun point.

Aurobindo Pharma looks to enhance focus on peptides

Aurobindo Pharma is set to up the focus on its peptide business and will be filing its first set of drug master files (DMFs) by the end of this fiscal.

Aurobindo Pharma to buy Natrol for $132.5 million

Emerges as the highest and best bidder to acquire the California-based company

Aurobindo Pharma set to buy US-based Natrol for $132.5 m

Aurobindo Pharma’s US subsidiary has emerged as the highest bidder for acquisition of Natrol Inc...

Aurobindo Pharma set to acquire US nutritional supplements maker Natrol for $133 mn

Buyout of Natrol would provide right platform for Aurobindo to create a fully-integrated OTC platform in the US.

Income Tax Calculator, Budget 2019, How to Calculate Income Tax

US Stock Market

View All


Stock Market

Most Read


Top News


Related Articles